Alere Inc  

(Public, NYSE:ALR)   Watch this stock  
Find more results for ALR
25.55
-0.49 (-1.88%)
May 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 25.38 - 25.97
52 week 17.13 - 29.57
Open 25.93
Vol / Avg. 708,985.00/721,850.00
Mkt cap 2.12B
P/E     -
Div/yield     -
EPS -1.09
Shares 83.06M
Beta 1.50
Inst. own 86%
Aug 5, 2013
Q2 2013 Alere Inc Earnings Release Add to calendar
Jun 13, 2013
Alere Inc at Goldman Sachs Healthcare Conference - 1:40PM EDT - Add to calendar
Jun 4, 2013
Alere Inc at Jefferies Global Healthcare Conference - 10:30AM EDT - Add to calendar
May 14, 2013
Alere Inc Annual Shareholder Meeting
May 9, 2013
Q1 2013 Alere Inc Earnings Conference Call
May 6, 2013
Q1 2013 Alere Inc Earnings Release
Mar 6, 2013
Alere Inc at Goldman Sachs Leveraged Finance Healthcare Conference
Mar 5, 2013
Alere Inc at Raymond James Institutional Investors Conference
Feb 26, 2013
Alere Inc at J.P. Morgan High Yield and Leveraged Finance Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 1.28% -3.23%
Operating margin 4.12% 3.86%
EBITD margin - 21.14%
Return on average assets 0.53% -1.33%
Return on average equity 1.87% -6.22%
Employees 17,400 -
Carbon Disclosure Rating - -

Address

Suite 200, 51 Sawyer Road
WALTHAM, MA 02453
United States - Map
+1-781-6473900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Alere Inc. is engaged in developing capabilities in near-patient diagnosis, monitoring and health management. The Company�s products and services, as well as its new product development efforts, focuses on cardiology, infectious disease, toxicology, diabetes, oncology and women�s health. The Company operates in three segments: professional diagnostics, health management and consumer diagnostics. In December 2011, the Company acquired Method Factory, Inc (doing business as, Wellogic). On November 23, 2011, the Company acquired Arriva Medical LLC (Arriva). On November 1, 2011, it acquired Axis-Shield plc (Axis-Shield). In November 2011, it acquired 1 Medical Distribution, Inc. On October 3, 2011, it acquired Avee Laboratories Inc. In February 2013, it acquired Epocal, Inc.

Officers and directors

Ron Zwanziger Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
David Teitel Chief Financial Officer, Vice President, Treasurer
Age: 48
Bio & Compensation  - Reuters
Michael Lester Cotton President and Chief Executive Officer of Alere Health, LLC
Age: 50
Bio & Compensation  - Reuters
Hilde Eylenbosch M.D. President, Europe and Middle East
Age: 48
Bio & Compensation  - Reuters
James Post President of Alere North America, Inc.
Age: 49
Bio & Compensation  - Reuters
David Toohey President - International Business Operations
Age: 55
Bio & Compensation  - Reuters
David Walton President, Asia Pacific
Age: 58
Bio & Compensation  - Reuters
Namal Nawana Chief Operating Officer
Age: 42
Bio & Compensation  - Reuters
Paul T. Hempel Senior Vice President - Ethics/Compliance, Special Counsel, Assistant Secretary
Age: 63
Bio & Compensation  - Reuters
Jerry McAleer Ph.D. Senior Vice President - Research and Development, Director
Age: 56
Bio & Compensation  - Reuters